Neogenomics (NEO) Shares Outstanding (2016 - 2025)
Neogenomics' Shares Outstanding history spans 16 years, with the latest figure at $129.0 million for Q4 2025.
- For Q4 2025, Shares Outstanding changed 0.0% year-over-year to $129.0 million; the TTM value through Dec 2025 reached $129.0 million, changed 0.0%, while the annual FY2025 figure was $129.0 million, 0.0% changed from the prior year.
- Shares Outstanding reached $128.1 million in Q4 2025 per NEO's latest filing, down from $128.9 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $129.0 million in Q4 2024 to a low of $117.1 million in Q1 2021.
- Average Shares Outstanding over 5 years is $126.3 million, with a median of $127.2 million recorded in 2023.
- Peak YoY movement for Shares Outstanding: rose 11.15% in 2021, then changed 0.0% in 2025.
- A 5-year view of Shares Outstanding shows it stood at $124.1 million in 2021, then rose by 2.26% to $126.9 million in 2022, then increased by 0.36% to $127.4 million in 2023, then rose by 1.27% to $129.0 million in 2024, then changed by 0.0% to $129.0 million in 2025.
- Per Business Quant, the three most recent readings for NEO's Shares Outstanding are $129.0 million (Q4 2025), $128.9 million (Q3 2025), and $128.7 million (Q2 2025).